Articles published by Tempus AI, Inc.
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting
March 29, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

Tempus Announces Acquisition of Deep 6 AI
March 11, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

Tempus Reports Fourth Quarter and Full Year 2024 Results
February 24, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

Tempus to Present at TD Cowen's 45th Annual Health Care Conference
February 19, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

Tempus to Participate in the Morgan Stanley Technology, Media and Telecom Conference
February 18, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

Tempus Announces Collaboration with IFLI Aimed at Supporting Development of Targeted Therapies for Follicular Lymphoma
February 13, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24
February 11, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

Tempus Completes Acquisition of Ambry Genetics
February 03, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

Tempus Announces National Launch of olivia, its AI-enabled Personal Health Concierge App for Patients
January 21, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

Tempus Announces the National Launch of FDA-Approved xT CDx Test
January 15, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM


Tempus Announces Its First-Ever, Whole-Genome Sequencing Assay, xH
January 13, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM


Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms
January 08, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

Tempus to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device
December 17, 2024
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM



Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care
November 11, 2024
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting
November 08, 2024
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM



Tempus to Report Third Quarter 2024 Financial Results on November 4
November 03, 2024
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM


Tempus to Report Third Quarter 2024 Financial Results on November 7
October 24, 2024
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM



Tempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients
September 12, 2024
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM

Tempus Announces Real World Data Collaboration with BioNTech
September 04, 2024
From Tempus AI, Inc.
Via Business Wire
Tickers
TEM
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.